Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations
Open Access
- 13 November 2009
- journal article
- Published by Springer Nature in Critical Care
- Vol. 13 (6) , R180
Abstract
Introduction: Systemic inflammatory response syndrome (SIRS) is a frequent condition after cardiopulmonary bypass (CPB) and makes conventional biological tests fail to detect postoperative sepsis. Biphasic waveform (BPW) analysis is a new biological test derived from activated partial thromboplastin time that has recently been proposed for sepsis diagnosis. The aim of this study was to investigate the accuracy of BPW to detect sepsis after cardiac surgery under CPB. Methods: We conducted a prospective study in American Society of Anesthesiologists' (ASA) physical status III and IV patients referred for cardiac surgery under CPB. Procalcitonin (PCT) and BPW were recorded before surgery and every day during the first week following surgery. Patients were then divided into three groups: patients presenting no SIRS, patients presenting with non-septic SIRS and patients presenting with sepsis. Results: Thirty two patients were included. SIRS occurred in 16 patients (50%) including 5 sepsis (16%) and 11 (34%) non-septic SIRS. PCT and BPW were significantly increased in SIRS patients compared to no SIRS patients (0.9 [0.5-2.2] vs. 8.1 [2.0-21.3] ng/l for PCT and 0.10 [0.09-0.14] vs. 0.29 [0.16-0.56] %T/s for BPW; P < 0.05 for both). We observed no difference in peak PCT value between the sepsis group and the non-septic SIRS group (8.4 [7.5-32.2] vs. 7.8 [1.9-17.5] ng/l; P = 0.67). On the other hand, we found that BPW was significantly higher in the sepsis group compared to the non-septic SIRS group (0.57 [0.54-0.78] vs. 0.19 [0.14-0.29] %T/s; P < 0.01). We found that a BPW threshold value of 0.465%T/s was able to discriminate between sepsis and non-septic SIRS groups with a sensitivity of 100% and a specificity of 93% (area under the curve: 0.948 +/- 0.039; P < 0.01). Applying the previously published threshold of 0.25%T/s, we found a sensitivity of 100% and a specificity of 72% to discriminate between these two groups. Neither C-reactive protein (CRP) nor PCT had significant predictive value (area under the curve for CRP was 0.659 +/- 0.142; P = 0.26 and area under the curve for PCT was 0.704 +/- 0.133; P = 0.15). Conclusions: BPW has potential clinical applications for sepsis diagnosis in the postoperative period following cardiac surgery under CPB.Keywords
This publication has 26 references indexed in Scilit:
- Assessment of the Accuracy of Procalcitonin to Diagnose Postoperative Infection after Cardiac SurgeryAnesthesiology, 2007
- Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complicationsIntensive Care Medicine, 2002
- The Systemic Inflammatory Response to Cardiac SurgeryAnesthesiology, 2002
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001
- Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrationsBritish Journal of Anaesthesia, 1999
- Activation of the Complement System During and After Cardiopulmonary Bypass SurgeryCirculation, 1997
- Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulationBritish Journal of Haematology, 1997
- Systemic inflammatory response syndrome after cardiac operationsThe Annals of Thoracic Surgery, 1996
- The ACCP-SCCM Consensus Conference on Sepsis and Organ FailureChest, 1992
- C‐reactive protein in patients undergoing cardiac surgeryAnaesthesia, 1986